Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
41°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Immuron Limited
Immuron to host Live Virtual Event
April 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® sales continued strong growth
April 10, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
March 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Presentation Australian Biologics Festival 2024
February 21, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record Travelan® sales
February 13, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
February 08, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record half yearly Travelan® sales
January 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Clinical Trials Update
December 22, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
December 04, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
November 28, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore presented at AusBioInvest
October 30, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Travelan® Clinical Study Cohort 2 commences
October 18, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record quarterly Travelan® sales
October 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record monthly Travelan® sales
September 13, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
September 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron to present at the Military Health System Research Symposium
August 14, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
July 25, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at Bioshares
July 24, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Business Update - Ateria Health launches Juvia™ in Australia
July 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron FY23 Sales increase 136% on FY22 Sales
July 05, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Chairman Transition
June 30, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
ASX:PNV
IMRN
Immuron Business Update: Letter to Shareholders
June 22, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Initiates Recruitment of Travelan® Clinical Study
May 30, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
May 08, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
May 02, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Q3 FY23 Business Update Presentation
April 19, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Q3 FY23 Business Update Webinar Notification
April 11, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Q3 Sales reach 150% of 1H Sales
April 06, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to host an investor webinar
February 15, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.